Pulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivity

Cardiovascular Toxicology

Volumn 13, Issue 4, 2013, Pages 323-337

  Minarchick, Valerie C ^a,b   Stapleton, Phoebe A ^a,b   Porter, Dale W ^b,c   Wolfarth, Michael G ^c   Çiftyürek, Engin ^d   Barger, Mark ^c   Sabolsky, Edward M ^d   Nurkiewicz, Timothy R ^a,b,c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d West Virginia University   (United States)

Author keywords

Arteriole; Cerium dioxide; Coronary; Engineered nanomaterial; Mesentery; Microcirculation

Indexed keywords

CERIUM DIOXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD FLOW VELOCITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERIOLE; LONG TERM EXPOSURE; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERIOLE; MICROANGIOPATHY; MICROCIRCULATION; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIOLES; CERIUM; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG; MALE; MESENTERIC ARTERIES; NANOPARTICLES; ORGAN CULTURE TECHNIQUES; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASODILATION;

EID: 84890552473     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9213-3     Document Type: Article

References (46)

1. Borm, P. J.; Robbins, D.; Haubold, S.; Kuhlbusch, T.; Fissan, H.; Donaldson, K.; et al. (2006). The potential risks of nanomaterials: A review carried out for ECETOC. Particle and Fibre Toxicology, 3, 11.
2. Hanson, N.; Harris, J.; Joseph, L. A.; Ramakrishnan, K.; & Thompson, T. EPA Needs to Manage Nanomaterial Risks More Effectively. 2011. Report No.: 12-P-0162.
3. Borm, P. J.; & Muller-Schulte, D. (2006). Nanoparticles in drug delivery and environmental exposure: Same size, same risks? Nanomedicine (Lond), 1(2), 235-249.
4. Aitken, R. J.; Chaudhry, M. Q.; Boxall, A. B.; & Hull, M. (2006). Manufacture and use of nanomaterials: Current status in the UK and global trends. Occupational Medicine (Lond), 56(5), 300-306.
5. Cassee, F. R.; van Balen, E. C.; Singh, C.; Green, D.; Muijser, H.; Weinstein, J.; et al. (2011). Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Critical Reviews in Toxicology, 41(3), 213-229.
6. Cassee, F. R.; Campbell, A.; Boere, A. J.; McLean, S. G.; Duffin, R.; Krystek, P.; et al. (2012). The biological effects of subacute inhalation of diesel exhaust following addition of cerium oxide nanoparticles in atherosclerosis-prone mice. Environmental Research, 115, 1-10.
7. Preisler, E. J.; Marsh, O. J.; Beach, R. A.; & McGill, T. C. (2001). Stability of cerium oxide on silicon studied by X-ray photoelectron spectroscopy. Journal of Vacuum Science and Technology B, 19(4), 1611-1618.
8. Geraets, L.; Oomen, A. G.; Schroeter, J. D.; Coleman, V. A.; & Cassee, F. R. (2012). Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: Results from a 28-day exposure study. Toxicology Science, 127(2), 463-473.
9. Yokel, R. A.; Au, T. C.; Macphail, R.; Hardas, S. S.; Butterfield, D. A.; Sultana, R.; et al. (2012). Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats. Toxicology Science, 127(1), 256-268.
10. Pairon, J. C.; Roos, F.; Sebastien, P.; Chamak, B.; Bd-Alsamad, I.; Bernaudin, J. F.; et al. (1995). Biopersistence of cerium in the human respiratory tract and ultrastructural findings. American Journal of Industrial Medicine, 27(3), 349-358.
11. Celardo, I.; Traversa, E.; & Ghibelli, L. (2011). Cerium oxide nanoparticles: A promise for applications in therapy. Journal of experimental therapeutics & oncology, 9(1), 47-51.
12. Heckert, E. G.; Karakoti, A. S.; Seal, S.; & Self, W. T. (2008). The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials, 29(18), 2705-2709.
13. Colon, J.; Herrera, L.; Smith, J.; Patil, S.; Komanski, C.; Kupelian, P.; et al. (2009). Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine, 5(2), 225-231.
14. Kim, C. K.; Kim, T.; Choi, I. Y.; Soh, M.; Kim, D.; Kim, Y. J.; et al. (2012). Ceria nanoparticles that can protect against ischemic stroke. Angewandte Chemie (International ed. in English), 51(44), 11039-11043.
15. Stapleton, P. A.; Minarchick, V. C.; McCawley, M.; Knuckles, T. L.; & Nurkiewicz, T. R. (2012). Xenobiotic particle exposure and microvascular endpoints: A call to arms. Microcirculation, 19(2), 126-142.
16. Ma, J. Y.; Zhao, H.; Mercer, R. R.; Barger, M.; Rao, M.; Meighan, T.; et al. (2011). Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology, 5(3), 312-325.
17. Toya, T.; Takata, A.; Otaki, N.; Takaya, M.; Serita, F.; Yoshida, K.; et al. (2010). Pulmonary toxicity induced by intratracheal instillation of coarse and fine particles of cerium dioxide in male rats. Industrial Health, 48(1), 3-11.
18. Schwartzkopff, B.; Mundhenke, M.; & Strauer, B. E. (1998). Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia. Journal of the American College of Cardiology, 31(5), 1089-1096.
19. Prewitt, R. L.; Rice, D. C.; & Dobrian, A. D. (2002). Adaptation of resistance arteries to increases in pressure. Microcirculation, 9(4), 295-304.
20. Zweifach, B. W. (1984). Pressure-flow relations in blood and lymph microcirculation. In E. M. Renkin & C. C. Michel (Eds.), Handbook of physiology (pp. 251-308). Bethesda, MD: American Physiological Society.
21. Renkin, E. M. (1984). Control of microcirculation and blood-tissue exchange. In E. M. Renkin & C. C. Michel (Eds.), Handbook of physiology (pp. 627-687). Bethesda, MD: American Physiology Society.
22. Wingard, C. J.; Walters, D. M.; Cathey, B. L.; Hilderbrand, S. C.; Katwa, P.; Lin, S.; et al. (2011). Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology, 5(4), 531-545.
23. Nalabotu, S. K.; Kolli, M. B.; Triest, W. E.; Ma, J. Y.; Manne, N. D.; Katta, A.; et al. (2011). Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats. International Journal of Nanomedicine, 6, 2327-2335.
24. LeBlanc, A. J.; Cumpston, J. L.; Chen, B. T.; Frazer, D.; Castranova, V.; & Nurkiewicz, T. R. (2009). Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. Journal of toxicology and environmental health. Part A, 72(24), 1576-1584.
25. Nurkiewicz, T. R.; Porter, D. W.; Barger, M.; Millecchia, L.; Rao, K. M.; Marvar, P. J.; et al. (2006). Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environmental Health Perspectives, 114(3), 412-419.
26. Tok, A. I. Y.; Du, S. W.; Boey, F. Y. C.; & Chong, W. K. (2013). Hydrothermal synthesis and characterization of rare earth doped ceria nanoparticles. Materials science & engineering, 466, 223-229.
27. Nurkiewicz, T. R.; Porter, D. W.; Barger, M.; Castranova, V.; & Boegehold, M. A. (2004). Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environmental Health Perspectives, 112(13), 1299-1306.
28. Porter, D. W.; Barger, M.; Robinson, V. A.; Leonard, S. S.; Landsittel, D.; & Castranova, V. (2002). Comparison of low doses of aged and freshly fractured silica on pulmonary inflammation and damage in the rat. Toxicology, 175(1-3), 63-71.
29. Sun, D.; Messina, E. J.; Kaley, G.; & Koller, A. (1992). Characteristics and origin of myogenic response in isolated mesenteric arterioles. American Journal of Physiology, 263(5 Pt 2), H1486-H1491.
30. Chilian, W. M.; Eastham, C. L.; & Marcus, M. L. (1986). Microvascular distribution of coronary vascular resistance in beating left ventricle. American Journal of Physiology, 251(4 Pt 2), H779-H788.
31. Kotani, A.; Jo, T.; & Parlebas, J. C. (2013). Many-body effects in core-level spectroscopy of rare-earth compounds. Advances in Physics, 37, 8952-8961.
32. Burroughs, P.; Hamnett, A.; Orchard, A. F.; & Thomton, G. (2013). Satellite structure in the X-ray photoelectron spectra of some binary and mixed oxides of lanthanum and cerium. Journal of the Chemical Society, Dalton Transactions, 17, 1686-1698.
33. Kumar, S.; Butcher, K. S. A.; & Tansley, T. L. (2013). X-ray photoelectron spectroscopy characterization of radio frequency reactively sputtered carbon nitride thin films. Journal of Vacuum Science and Technology A, 14(5), 2687-2692.
34. Grossi, L.; & D'Angelo, S. (2005). Sodium nitroprusside: Mechanism of NO release mediated by sulfhydryl-containing molecules. Journal of Medicinal Chemistry, 48(7), 2622-2626.
35. Stone, K. C.; Mercer, R. R.; Gehr, P.; Stockstill, B.; & Crapo, J. D. (1992). Allometric relationships of cell numbers and size in the mammalian lung. American Journal of Respiratory Cell and Molecular Biology, 6(2), 235-243.
36. Galer, D. M.; Leung, H. W.; Sussman, R. G.; & Trzos, R. J. (1992). Scientific and practical considerations for the development of occupational exposure limits (OELs) for chemical substances. Regulatory Toxicology and Pharmacology, 15(3), 291-306.
37. Phalen, R. F. (1984). Basic morphology and physiology of the respiratory tract, in inhalation studies: Foundations and techniques. Boca Raton: CRC Press.
38. Nurkiewicz, T. R.; Porter, D. W.; Hubbs, A. F.; Stone, S.; Moseley, A. M.; Cumpston, J. L.; et al. (2011). Pulmonary particulate matter and systemic microvascular dysfunction. Research Report/Health Effects Institute, 164, 3-48.
39. Menache, M. G.; Miller, F. J.; & Raabe, O. G. (1995). Particle inhalability curves for humans and small laboratory animals. Annals of Occupational Hygiene, 39(3), 317-328.
40. LeBlanc, A. J.; Moseley, A. M.; Chen, B. T.; Frazer, D.; Castranova, V.; & Nurkiewicz, T. R. (2010). Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovascular Toxicology, 10(1), 27-36.
41. Stapleton, P. A.; Minarchick, V. C.; Cumpston, A. M.; McKinney, W.; Chen, B. T.; Sager, T. M.; et al. (2012). Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: A time-course study. International Journal of Molecular Sciences, 13(11), 13781-13803.
42. Courtois, A.; Andujar, P.; Ladeiro, Y.; Baudrimont, I.; Delannoy, E.; Leblais, V.; et al. (2008). Impairment of NO-dependent relaxation in intralobar pulmonary arteries: Comparison of urban particulate matter and manufactured nanoparticles. Environmental Health Perspectives, 116(10), 1294-1299.
43. Straub, A. C.; Lohman, A. W.; Billaud, M.; Johnstone, S. R.; Dwyer, S. T.; Lee, M. Y.; et al. (2012). Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling. Nature, 491(7424), 473-477.
44. Park, E. J.; Choi, J.; Park, Y. K.; & Park, K. (2008). Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology, 245(1-2), 90-100.
45. Driscoll, K. E.; Costa, D. L.; Hatch, G.; Henderson, R.; Oberdorster, G.; Salem, H.; et al. (2000). Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: Uses and limitations. Toxicological Sciences, 55(1), 24-35.
46. He, X.; Zhang, H.; Ma, Y.; Bai, W.; Zhang, Z.; Lu, K.; et al. (2010). Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology, 21(28), 285103.